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1. INTRODUCTION
Raised Blood Pressure (BP) is the number one modifiable risk 
factor for cardiovascular disease, which causes approximately one 
in three deaths globally [1]. Clinical measurement of BP is per-
formed with an inflatable upper-arm cuff and sphygmomanometer. 
The method was first described by Scipione Riva-Rocci in 1896 
[2,3]. In 1905, Nikolai Korotkoff reported five distinct sounds that 
can be identified by auscultation of the brachial artery during cuff 
deflation [4]. The most well-known are the 1st and 5th Korotkoff 
sounds, which correspond to Systolic BP (SBP) and Diastolic BP 
(DBP) respectively [2]. Since the 1970s automated devices have 
increased in popularity. The most common method to estimate 
BP with automated devices is the oscillometric technique. In this 
method, an oscillometric envelope is generated from oscillations in 
pressure throughout cuff deflation and device-specific methods are 
used to estimate BP [5].
Cuff BP is undoubtedly a powerful predictor of cardiovascular 
risk and is invariably used for management of BP in clinical prac-
tice [6,7]. The accurate measurement of BP is fundamental to the 
optimal detection, treatment and management of raised BP [8]. 
However, after more than 100 years, questions still remain on 
the accuracy of cuff BP compared with gold-standard invasive 
BP measurements. Resolving questions on the accuracy of BP 
measurement is critically important because as little as 5 mmHg 
measurement error could result in misclassification of hyperten-
sion in 84 million people worldwide [9], and lead to inaccura-
cies in perceived hypertension prevalence and control rates [10]. 
The potential implications of underestimated BP are that patients 
may be left at unnecessarily high cardiovascular risk because life-
style modification and/or pharmacological treatment has not been 
initiated. On the other hand, overestimation of BP may lead to 
initiation of unnecessary lifelong BP medications along with the 
associated costs and potential side-effects. The aim of this review is 
to describe our recent work to understand the accuracy of cuff BP 
compared with invasive BP, critical physiological factors associated 
with inaccuracy and future directions for the field.
2.  ACCURACY OF CUFF BP COMPARED 
WITH INVASIVE BP
The INvaSive blood PressurE ConsorTium (INSPECT) was estab-
lished to improve understanding of cuff BP accuracy compared 
with gold-standard invasive (intra-arterial) BP. Following an exten-
sive systematic review, the consortium compiled data from more 
than 3000 individual patients from over 30 studies. Recently three 
distinct, but closely aligned research questions were addressed: 
(1) invasive aortic BP compared with invasive brachial BP; (2) cuff 
BP compared with invasive brachial BP; and (3) cuff BP compared 
with invasive aortic BP. Inclusion criteria for the consortium data-
base included measurement of cuff BP during the invasive BP pro-
cedure (not, for example, in a waiting bay prior to the measurement 
of invasive BP) and measurement of BP under baseline conditions. 
The full inclusion and exclusion criteria have been published [11].
2.1.  Invasive Aortic Compared with  
Invasive Brachial BP
The original purpose of cuff BP was to measure central aortic 
BP [3]. This is logical because the BP in the central arteries 
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Figure 1 | Schematic illustrating level of invasive aortic-to-brachial Blood Pressure (BP) amplification and the differences in cuff BP compared  
with invasive brachial and invasive aortic BP.
causes major adverse cardiovascular events, not the BP in the 
periphery. But, arterial signals from the brachial artery are used 
for cuff BP, which suggests the measurement should correspond 
to invasive brachial BP. Therefore, the true level of difference 
between the aorta and brachial artery (BP amplification) has 
implications for understanding whether cuff BP measures inva-
sive aortic or brachial BP. In recently published work using 
the INSPECT database [11], 515 subjects (mean age 59 years, 
72% male) from 13 studies, the average invasive aortic-to- 
brachial SBP amplification was 8.0 mmHg (Figure 1). However, 
SBP amplification was highly variable among individuals [11], 
which creates uncertainty on whether cuff BP measures invasive 
brachial BP or invasive aortic BP. To try to resolve this uncer-
tainty, both these questions were examined using the INSPECT 
database [11].
2.2.  Cuff BP Compared with Invasive  
Brachial BP
In the meta-analysis of cuff and invasive brachial BP, the analysis 
was conducted on 735 subjects (mean age 53 years, 62% male). 
Cuff SBP systematically underestimated invasive brachial SBP by 
−5.7 mmHg, and systematically overestimated invasive brachial 
DBP by 5.5 mmHg (Figure 1). In a sub-analysis, underestimation 
of SBP was on average higher using oscillometric compared with 
mercury sphygmomanometry (−8.0 mmHg vs. −3.4 mmHg), 
although the mean absolute difference between the two methods 
was similar (oscillometric: 8.1 mmHg vs. mercury: 7.5 mmHg). 
These analyses showed that cuff SBP underestimated invasive 
brachial SBP but because of aortic-to-brachial SBP amplification, 
cuff BP might be a reasonable approximate of invasive aortic SBP 
(Figure 1) [11].
2.3.  Cuff BP Compared with Invasive  
Aortic BP
Cuff BP was compared with invasive aortic BP in 1823 subjects 
(mean age 60 years, 70% male) from 39 individual studies in the 
INSPECT database [11]. There was no difference between cuff and 
invasive aortic SBP (0.3 mmHg; Figure 1). However, in many individ-
uals, cuff SBP substantially underestimated or overestimated invasive 
aortic SBP. This large individual variability was exemplified by only 
33% of cuff and invasive aortic (or brachial) SBP measurements fall-
ing within ±5 mmHg of each other. Moreover, in the BP range of 
120–159/80–99 mmHg (pre-hypertension and stage 1 hypertension 
according to JNC7 guidelines) [12], there was only 52–57% concor-
dance between cuff and invasive aortic BP [11]. This level of discor-
dance may have major ramifications for accurate classification and 
management of BP because most of the world’s population has a SBP 
in the range of 120–159 mmHg [13]. Cuff overestimation of inva-
sive aortic DBP was essentially the same magnitude as the brachial 
DBP analysis. This was unsurprising because DBP is relatively con-
sistent through the large arteries compared with SBP [11]. A second 
study recently published from the INSPECT database also showed 
that invasive aortic SBP and DBP are respectively under- and over- 
estimated to a greater level with increasing age [14]. Altogether, these 
data support the need to improve the accuracy of cuff BP. The need 
for accurate cuff SBP is probably more important than cuff DBP 
because it is a stronger predictor of cardiovascular risk [15–17].
2.3.1.  Technical aspects underlying cuff  
BP inaccuracy
There are several technical aspects that may contribute to inac-
curacy of cuff BP measurements. First, a faster the cuff deflation 
 D.S. Picone / Artery Research. In Press 3
rate will lead to greater underestimation of SBP and overestimation 
of DBP [18]. This relationship is also modulated by the patient’s 
heart rate. Second, for the auscultatory method, there may be a 
delay between the time the cuff deflation crosses the true SBP and 
the Korotkoff sound [18]. Third, physiological respiratory varia-
tion may also lead to errors in BP measurement [19]. Finally, it is 
also important to note that there may be some methods that show 
better agreement with invasive BP than others. For example, 
wideband recording of the brachial waveform can give excellent 
agreement with invasive brachial BP, potentially even superior to 
auscultation [20]. Other issues that may influence the accuracy of 
cuff BP have previously been discussed in detail [21], and are not 
the focus of this review.
3.  ARTERIAL PHYSIOLOGY UNDERPINNING 
PROBLEMS WITH CUFF ACCURACY
3.1.  Phenotypes of Blood Pressure  
Amplification and Cuff BP  
Measurement Accuracy
Amplification of SBP and pulse pressure from the heart to the 
peripheral arteries is a well-established physiological phenome-
non [11,22]. Large individual variability of BP amplification could 
have implications for the accuracy of cuff BP [11]. In our recently 
published work [23], we addressed this issue with measurements of 
invasive BP at the aorta, brachial and radial arteries via sequential 
catheter pullback, as well as cuff BP. This protocol allowed mea-
surement of SBP amplification from the proximal aorta through 
the entire upper-limb. The study enrolled 126 patients (mean age 
61 years, 69% male) undergoing coronary angiography and four 
distinct BP phenotypes were discovered based on changes in SBP 
amplification across the aorta-to-brachial and brachial-to-radial 
arteries (≥5 mmHg change = SBP amplification; <5 mmHg change 
= no SBP amplification; Figure 2) [23]. The critical finding was 
that patients with no aortic-to-brachial SBP amplification (pheno-
types three and four) had significantly higher invasive aortic BP 
compared with those with SBP amplification (phenotypes one and 
two). Most importantly, there was no difference in standard cuff 
BP in those with no SBP amplification versus SBP amplification, 
despite cuff BP being taken with multiple different devices at differ-
ent times. The observations were confirmed with data from inde-
pendent investigators in Italy, China and Taiwan.
We hypothesised cardiovascular risk may be higher for those with 
no aortic-to-brachial SBP amplification versus those with SBP 
amplification. This was because invasive aortic BP was higher in 
patients without SBP amplification, despite no difference in cuff BP. 
However, it is important to note that diagnoses of high BP should 
be made from multiple BP measurements at different times [2], 
which was not possible in this study. Our research team are now 
assessing the clinical relevance of the different SBP amplification 
phenotypes via associations with target organ damage and a large, 
prospective trial with follow up to cardiovascular events.
Alongside the potential implications for cardiovascular risk related 
to BP, the BP physiology related to SBP amplification may provide 
insights on how to improve the accuracy of cuff BP. Across the 
different SBP amplification phenotypes there were distinct differ-
ences in the arterial waveform shape. Importantly, standard cuff BP 
methods do not use information from the arterial waveform in the 
measurement of BP which neglects a vast amount of physiological 
information that should be considered in future work to improve 
cuff BP accuracy [23].
Figure 2 | Blood Pressure (BP) phenotypes according to variation in systolic BP amplification from the aorta-to-brachial-to-radial arteries. Figure from 
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Figure 3 | Variation in brachial-to-radial Systolic Blood Pressure (SBP) amplification observed in two subjects where fluid-filled catheters were withdrawn 
from the brachial-to-radial arteries at approximately 5 cm increments. The top subject exhibits major SBP amplification, while the bottom subject exhibits 
no SBP amplification. Figure adapted from Armstrong et al. [28] and republished in accordance with the AHA Copyright Transfer Agreement.
One limitation of this work is that the reproducibility of the SBP 
amplification phenotypes is unknown because it was not possible 
to record repeated visit data. Another potential limitation is that 
the SBP amplification profile may change across a 24-h period and 
this could influence the phenotype observations. It is not possible 
to capture 24-h invasive SBP amplification data, but non-invasive 
ambulatory central aortic BP may provide useful insights on the 
circadian pattern of SBP amplification.
3.2.  Potential Implications of  
Brachial-to-Radial BP Amplification  
on Accurate BP Measurement
Most research on BP amplification has focussed on the aortic- 
to-brachial arteries, not the brachial-to-radial arteries. However, 
brachial-to-radial SBP amplification could be important for accu-
rate measurement of BP from ‘wearable’ devices worn at the wrist 
for measurement of BP. If these devices aim to represent conven-
tional brachial cuff BP, they may need to account for any differ-
ences in BP between the brachial and radial artery. Some authors 
suggest there are negligible differences between brachial and radial 
SBP and pulse pressure [24]; however, data from small invasive 
BP studies has shown brachial-to-radial SBP amplification exists 
[25,26]. We recently examined this issue using the largest invasive 
sample size to date (180 patients, mean age 61 years, 69% male) 
[27]. In this work invasive BP recordings were taken at the brachial 
and radial arteries. We found 43% of patients had radial SBP within 
±5 mmHg of brachial SBP. Indeed, 46% of patients had radial SBP 
that was ≥5 mmHg higher than the brachial SBP, altogether indi-
cating similar levels of individual variability in brachial-to-radial 
SBP amplification as the aorta-to-brachial arteries. This variability 
is exemplified in Figure 3, which shows gradual catheter pullback 
from the brachial-to-radial artery in two subjects, one with and one 
without brachial-to-radial SBP amplification [28]. Overall, the data 
from this study suggest that if biometric signals from the wrist are 
intended to estimate brachial SBP, the potential impact of brachial- 
to-radial SBP amplification on accuracy must be considered.
4.  ACCURACY OF ESTIMATED CENTRAL 
AORTIC BLOOD PRESSURE DEVICES
The usefulness of estimated central (aortic) BP remains unre-
solved [29,30]. As alluded to earlier, there is a strong physiolog-
ical rationale that central aortic BP may be a better predictor of 
cardiovascular risk than peripheral BP. However, there are myriad 
issues which plague the accuracy of devices that estimate central 
BP [31], including: (1) uncertainty on the best waveform calibration 
method [32]; (2) reliance on cuff BP for calibration of waveforms 
[33]; (3) failing to account for brachial-radial BP amplifica-
tion (only applicable to radial tonometry methods) [34–37]; and 
(4) device-specific results due to different algorithms for the esti-
mation of BP [31,32,38]. This final point has led to devices that 
estimate central BP being described as either ‘type I’ or ‘type II’ [31]. 
Type I refers to the devices that preserve the difference in central 
and brachial BP, meaning that BP amplification may be relatively 
accurate, despite substantial underestimation of central SBP (due to 
the calibration from cuff SBP underestimating the true underlying 
invasive waveform values) [32]. On the other hand, type II devices 
aim to estimate aortic BP as accurately as possible. These devices 
usually function by recalibration of the peripheral waveform with 
Mean Arterial Pressure (MAP) and DBP.
4.1.  Implications of BP Amplification  
on Waveform Calibration
There is uncertainty on the most accurate calibration method to 
estimate central BP. In an attempt to resolve this issue, we con-
ducted a study in which different calibration modes were tested 
using accurate, invasive BP to eliminate the problem of relying on 
inaccurate cuff BP calibration of peripheral waveforms [33]. In 
the study, 107 patients (mean age 62 years, 70% male) undergoing 
coronary angiography had invasive radial waveforms calibrated 
with either brachial SBP/DBP (the method popularised by the 
SphygmoCor system) [39], or brachial MAP (area under the curve)/
DBP. Estimated central BP was generated by the SphygmoCor 
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CVMS system via retrospective waveform processing using the 
software simulation mode. The results showed central BP estimates 
were significantly less accurate using the SBP/DBP calibration than 
MAP/DBP [40]. There were strong correlations of the difference 
in estimated and measured central aortic BP (i.e. accuracy) with 
aortic-brachial or brachial-radial SBP amplification. This indi-
cates that further research to understand the causes of variable SBP 
amplification may assist to improve algorithms (e.g. generalised 
transfer function) used to estimated central BP. Any improvements 
to the algorithms must be coupled with an appropriate way to 
calibrate peripheral waveforms [33,36,37].
A potential solution for the accuracy problems that plague esti-
mated central aortic BP was recently published [41]. The authors 
used a unique method to directly analyse the internal cuff pres-
sure waveform from standard cuff inflation and deflation, instead 
of performing an additional inflation like most other devices 
on the market. The exact details are not known because this is 
a device-specific approach, but the work represents an import-
ant innovation for BP measurement and importantly passed the 
ARTERY Society protocol [31] when compared with invasive 
aortic SBP and DBP. Nevertheless, independent validation of 
device accuracy and studies on clinical relevance of the data from 
this device are needed.
5. FUTURE DIRECTIONS
Ongoing work to understand the physiological factors that 
contribute to the inaccuracy of cuff BP is needed. Such data will 
be critical for informing efforts to improve the accuracy of cuff BP. 
Some current work to improve the accuracy of BP measurement 
has involved deeper analysis of waveform information captured 
during oscillometry [41,42]. In the future methods that harness 
modern analytics, including artificial intelligence may help to 
improve BP measurement accuracy.
Aside from cuff techniques, it is also important to acknowledge 
that many cuff-less BP measurement approaches are under devel-
opment [43,44]. The potential of cuff-less BP measurement is 
exciting, but measurement accuracy must not be overlooked [45–47]. 
There are already many cuff-less wrist wearable activity tracking 
style devices that purport to measure BP available online that have 
not undergone rigorous testing for accuracy [46,48].
6. SUMMARY
Cuff BP has been the cornerstone for the clinical management of 
raised BP for over 100 years. The data presented in this review 
does not dispute the evidence base on the associations of cuff BP 
with adverse clinical outcomes. Nevertheless, cuff BP is quite crude 
and our individual participant data meta-analyses have shown it 
is inaccurate in many people. We have also shown that a critical 
physiological factor associated with inaccuracy of BP measurement 
is SBP amplification. Taken together, our data suggest that improv-
ing the accuracy of BP measurement methods should be a research 
priority. Achieving this goal could lead to even better prediction of 
risk from BP measurements, leading to improved clinical practice 
and patient health outcomes through more accurate diagnosis and 
management of raised BP.
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